Effects of CRISPR/Cas9 targeting of the myo-inositol biosynthesis pathway on hyper-osmotic tolerance of tilapia cells

被引：2
|
作者：
Hamar, Jens [1 ,2 ]
Cnaani, Avner [3 ]
Kultz, Dietmar [1 ,2 ]
机构：
[1] Univ Calif Davis, Dept Anim Sci, Meyer Hall,1 Shields Ave, Davis, CA 95616 USA
[2] Univ Calif Davis, Genome Ctr, Meyer Hall,1 Shields Ave, Davis, CA 95616 USA
[3] Agr Res Org, Inst Anim Sci, Volcani Ctr, Dept Poultry & Aquaculture, POB 15159, IL-7528809 Rishon Leziyyon, Israel
来源：
GENOMICS | 2024年 / 116卷 / 03期
基金：
美国国家科学基金会;
关键词：
CRISPR/Cas9; Osmoregulation; Salinity; Myo-inositol; Oreochromis tilapia; PENTOSE-PHOSPHATE PATHWAY; NILE TILAPIA; OREOCHROMIS-NILOTICUS; ENVIRONMENTAL SALINITY; VOLUME REGULATION; MYOINOSITOL TRANSPORT; OXYGEN-CONSUMPTION; GLUCOSE-METABOLISM; ORGANIC OSMOLYTES; PLASMA OSMOLALITY;
D O I：
10.1016/j.ygeno.2024.110833
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Myo-inositol is an important compatible osmolyte in vertebrates. This osmolyte is produced by the myo-inositol biosynthesis (MIB) pathway composed of myo-inositol phosphate synthase and inositol monophosphatase. These enzymes are among the highest upregulated proteins in tissues and cell cultures from teleost fish exposed to hyperosmotic conditions indicating high importance of this pathway for tolerating this type of stress. CRISPR/ Cas9 gene editing of tilapia cells produced knockout lines of MIB enzymes and control genes. Metabolic activity decreased significantly for MIB KO lines in hyperosmotic media. Trends of faster growth of the MIB knockout lines in isosmotic media and faster decline of MIB knockout lines in hyperosmotic media were also observed. These results indicate a decline in metabolic fitness but only moderate effects on cell survival when tilapia cells with disrupted MIB genes are exposed to hyperosmolality. Therefore MIB genes are required for full osmotolerance of tilapia cells.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] TARGETING HBx BY CRISPR/Cas9 SYSTEM EFFECTIVELY REDUCES THE EMT AND STEMNESS CHARACTERISTICS OF HCC CELLS IN VITRO
    Rawal, Preety Rawal
    Tripathi, Dinesh Mani
    Sarin, Shiv Kumar
    Nain, Vikrant
    Kaur, Savneet
    HEPATOLOGY, 2020, 72 : 61A - 61A
  • [22] Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection
    Cottle, Renee N.
    Lee, Ciaran M.
    Archer, David
    Bao, Gang
    SCIENTIFIC REPORTS, 2015, 5
  • [23] Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting
    Lopes, Carla
    Tang, Yang
    Anjo, Sandra, I
    Manadas, Bruno
    Onofre, Isabel
    de Almeida, Luis P.
    Daley, George Q.
    Schlaeger, Thorsten M.
    Carvalho Rego, Ana Cristina
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [24] Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection
    Renee N. Cottle
    Ciaran M. Lee
    David Archer
    Gang Bao
    Scientific Reports, 5
  • [25] CMBs carrying PTX and CRISPR/Cas9 targeting C-erbB-2 plasmids interfere with endometrial cancer cells
    Peng, Siyuan
    Cai, Junhong
    Bao, Shan
    MOLECULAR MEDICINE REPORTS, 2021, 24 (06)
  • [26] Allogeneic CRISPR/Cas9 gene-edited CAR-T cells targeting CD33 show potent cells
    McEwan, Brigid
    Padalia, Zinkal
    Porras, Ashley
    Sagert, Jason
    Terrett, Jonathan A.
    Ho, Tony
    Kalaitzidis, Demetrios
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway
    Lee, Jae Seong
    Kallehauge, Thomas Beuchert
    Pedersen, Lasse Ebdrup
    Kildegaard, Helene Faustrup
    SCIENTIFIC REPORTS, 2015, 5
  • [28] Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway
    Jae Seong Lee
    Thomas Beuchert Kallehauge
    Lasse Ebdrup Pedersen
    Helene Faustrup Kildegaard
    Scientific Reports, 5
  • [29] The effect of IGFBP3 gene knockout by the CRISPR/Cas9 system on the IGF-1 pathway in murine cells
    Eom, Su Yeon
    Kim, Moon-Moo
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2024, 125
  • [30] Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells
    Tavazohi, Nazita
    Mirian, Mina
    Varshosaz, Jaleh
    Shirani-Bidabadi, Shiva
    Sadeghi, Hamid Mir Mohammad
    Khanahmad, Hossein
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 86
12345